SCHEMBL16609461

SCHEMBL16609461

Clc1cc2[nH]c(C3CC3)nc2cc1Br

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPY5R Q15761 3/20 0.44
▸ NPC1 O15118 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ MAPT P10636 3/20 0.42
▸ KDM4E B2RXH2 2/20 0.42
▸ GFER P55789 1/20 0.42
▸ ALDH1A1 P00352 2/20 0.39
▸ LMNA P02545 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ GMNN O75496 1/20 0.38
▸ BLM P54132 1/20 0.38
▸ PMP22 Q01453 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ NFKB1 P19838 1/20 0.38
▸ STAT6 P42226 1/20 0.38
▸ HIF1A Q16665 1/20 0.38
▸ CACNA1G O43497 1/20 0.38
▸ CACNA1H O95180 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16599521 0.94 NPY5R (0.44) NPY5RNPC1RAB9AMAPTKDM4E
SCHEMBL16609509 0.81 NPC1 (0.50) NPC1RAB9AMAPTKDM4EGFER
SCHEMBL16599668 0.77 NPC1 (0.50) NPC1RAB9AMAPTKDM4EGFER
SCHEMBL5407734 0.77 NPY5R (0.50) NPY5RNPC1RAB9AMAPTKDM4E
SCHEMBL31748325 0.75 CSNK2A1 (0.44) NPC1RAB9ALMNACACNA1GCACNA1H
SCHEMBL30390480 0.73 NPY5R (0.45) NPY5RNPC1RAB9AMAPTKDM4E
SCHEMBL10834057 0.73 CSNK2A1 (0.42) NPC1RAB9ALMNACACNA1GCACNA1H
SCHEMBL28995775 0.72 NPC1 (0.41) NPY5RNPC1RAB9AMAPTKDM4E
SCHEMBL14447537 0.70 KCNH2 (0.48) NPY5RNPC1RAB9AALDH1A1
SCHEMBL22600526 0.69 HRH4 (0.40) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160280688-A1 SUBSTITUTED PHENYLALANINE DERIVATIVES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2016-09-29 — — US disclosed
US-20160280688-A1 SUBSTITUTED PHENYLALANINE DERIVATIVES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2016-09-29 — — US disclosed
WO-2015044174-A1 SUBSTITUTED PHENYLALANINE DERIVATIVES AS MODULATORS OF FACTOR XIA BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2015-04-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160280688-A1 SUBSTITUTED PHENYLALANINE DERIVATIVES PAH, PEPD, AADAT NPY5R 578/4885NPC1 4114/4885RAB9A 3497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback